Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|May 14, 2022
A2B5 Expression in Central Nervous System and GliomasDominique Figarella-Branger, Carole Colin, Nathalie Baeza-Kallee, et al.
Neuro-Oncology Advances|April 9, 2024
GD3 ganglioside is a promising therapeutic target for glioma patientsVictoria Hein, Nathalie Baeza-Kallee, Alexandre Bertucci, et al.
Cell Death & Disease|September 26, 2018
Proscillaridin A exerts anti-tumor effects through GSK3β activation and alteration of microtubule dynamics in glioblastomaRaphael Berges, Emilie Denicolai, Aurélie Tchoghandjian, et al.
Cancers|August 31, 2019
Glycolipids Recognized by A2B5 Antibody Promote Proliferation, Migration, and Clonogenicity in Glioblastoma CellsNathalie Baeza-Kallee, Raphaël Bergès, Aurélie Soubéran, et al.
Oncotarget|December 5, 2014
End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivoRaphael Berges, Nathalie Baeza-Kallee, Emeline Tabouret, et al.
Annals of Surgical Oncology|October 13, 2011
Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo propertiesAurélie Tchoghandjian, Nathalie Baeza-Kallee, Christophe Beclin, et al.
Experimental Cell Research|December 21, 2013
Ex vivo cultures of glioblastoma in three-dimensional hydrogel maintain the original tumor growth behavior and are suitable for preclinical drug and radiation sensitivity screeningCarine Jiguet Jiglaire, Nathalie Baeza-Kallee, Emilie Denicolaï, et al.
Oncotarget|November 18, 2014
Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivoEmilie Denicolaï, Nathalie Baeza-Kallee, Aurélie Tchoghandjian, et al.
Frontiers in Immunology|January 7, 2025
Metabolic adaptation of myeloid cells in the glioblastoma microenvironmentNora Essakhi, Alexandre Bertucci, Nathalie Baeza-Kallee, et al.
International Journal of Molecular Sciences|July 29, 2023
Deciphering the Action of Neuraminidase in Glioblastoma ModelsNathalie Baeza-Kallee, Raphaël Bergès, Victoria Hein, et al.
Pageof 2